July 26, 2011
Survey Finds More Than One in Three Americans Have Been Personally Affected By Infections Resulting From a Hospital Stay
IRVINE, Calif., July 26, 2011 /PRNewswire/ -- Survey results released today reveal that 34 percent of Americans(1) have, or know someone who has, acquired an infection after being exposed to germs during a hospital stay. Moreover, the survey found that 64 percent of Americans do not think they would be better protected from germs in the hospital than in their daily lives. The findings released today underscore that healthcare-associated infections (HAIs) are affecting perceptions of the safety of healthcare facilities and that new technologies are needed to help protect patients from hospital germs, including superbugs such as methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa (Pseudomonas) and E. coli. These superbugs can result in HAIs, which occur in nearly two million patients each year,(2) and lead to extended hospital stays, additional healthcare costs and patient deaths.
The survey, which was conducted online by Harris Interactive on behalf of Advanced Sterilization Products (ASP), also found:
- Nearly 99 percent of Americans understand that the cleanliness of patient rooms has an impact on the spread of infections in hospitals.
- Americans are making decisions about where to receive hospital care based on where they perceive they will receive the safest care. In fact, 75 percent of Americans say it is more important to choose a hospital based on lower infection rates rather than on convenience when in a non-emergency situation.
- An overwhelming number (94 percent) of Americans would prefer seeking care at a hospital that uses the latest technology available for preventing the spread of infection.
New Technology Disinfects the Healthcare Environment to Protect Against the Risk of HAIs
According to the latest scientific research, contamination of the hospital environment, which includes hospital rooms and operating suites, plays an important role in the transmission of many superbugs that cause HAIs.(3) Superbugs MRSA and Pseudomonas are tough to eliminate and can continue to live on surfaces in the patient environment after standard cleaning.(4)(5)( )However, studies show healthcare facilities can reduce the number of pathogens in the hospital environment by introducing enhanced deep cleaning and disinfection protocols to augment manual cleaning practices.(6)
ASP's GLOSAIR(TM) Healthcare Environmental Decontamination is an innovative new disinfection technology that was designed specifically for the healthcare environment to deliver thorough environmental disinfection in a way that is safe for patients, healthcare staff and medical equipment. Studies have shown hydrogen peroxide vapor decontamination devices, such as GLOSAIR(TM) Systems, are effective at reducing surface contamination by pathogens in hospital rooms and operating suites and may be associated with a reduction in infection transmission.(7) GLOSAIR(TM) Systems work by creating a mist of approximately 5 percent hydrogen peroxide that is uniformly dispersed to disinfect all hard nonporous surfaces, including difficult-to-reach areas.
"Patients should not need to question the safety of the healthcare environment," said Dr. Utpal Khambholja, ASP's Medical Officer. "ASP is excited to introduce GLOSAIR(TM) Healthcare Environmental Decontamination, which has been shown effective against pathogens that cause HAIs. GLOSAIR(TM), when used to augment manual cleaning processes, can provide healthcare facilities and patients with increased confidence that the patient environment has been thoroughly disinfected against the many bacteria and viruses that cause HAIs."
In a recent study of GLOSAIR(TM) technology, Nottingham University Hospital in the United Kingdom used GLOSAIR(TM) Systems in 11 rooms of its three elder-care wards and found GLOSAIR(TM) Systems successfully removed pathogens in high-risk clinical areas.(8) Due to the effectiveness of the system, following the study Nottingham University Hospital adopted GLOSAIR(TM) Systems as part of its routine infection control measures.
The GLOSAIR(TM) System is also used by Dorset County Hospital in England to help reduce its HAI rates.(9) "These machines have helped us maintain a good standard of cleaning and manage a safe patient environment," says Paul Andrews, Housekeeping Manager, Dorset County Hospital. "We've achieved one of the lowest MRSA rates in the National Health System since adding GLOSAIR(TM) Systems to our infection-prevention practices."
About the Survey
This survey was conducted online within the United States by Harris Interactive on behalf of Advanced Sterilization Products from April 8-12, 2011 among 2,483 U.S. adults ages 18 and older. Respondents for this survey were selected from among those who have agreed to participate in Harris Interactive surveys. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables, please contact Katie Sweet at [email protected]
About GLOSAIR(TM) Healthcare Environmental Decontamination
Building upon ASP's nearly 25 years of experience providing hydrogen peroxide technologies to meet the sterilization and disinfection needs of healthcare facilities worldwide, GLOSAIR(TM) Healthcare Environmental Decontamination provides effective, safe and thorough disinfection of patient environments, such as patient and hospital rooms as well as operation suites. GLOSAIR(TM) Systems disinfect by creating a fog of 5 percent hydrogen peroxide that is uniformly dispersed to all hard nonporous surfaces in the healthcare environment, including difficult-to-reach areas. Use of GLOSAIR(TM) Systems to augment manual cleaning processes can provide healthcare facilities and patients with increased confidence that the patient environment has been thoroughly and properly disinfected against many pathogens that cause healthcare-associated infections (HAIs).
About Advanced Sterilization Products (ASP)
Protecting Lives Against InfectionÃ®
Advanced Sterilization Products (ASP) is a leading developer of innovative infection prevention technologies. The company is dedicated to protecting patients, healthcare workers, and the environment with products that focus as much on safety as they do on efficacy and cost-effectiveness. Utilizing advanced instrument processing technologies, these products help customers to promote positive patient outcomes while controlling costs, increasing productivity, and enhancing safety. The company is based in Irvine, California, USA. Please visit ASP at www.ASPJJ.com or follow us on Twitter @ASPJJ.
(1) For the purposes of this survey, Americans were defined as US adults age 18+.
(2) CDC; Estimating Healthcare-Associated Infections and Death in US Hospitals, 2002. Public Health Reports. 2007, 122, 1. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/hicpac/infections_deaths.pdf.
(3) Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010; 38 (5 Suppl 1): S25-S33.
(4) Boyce JM. J Hosp Infect. 2007; 65(Suppl 2): 50-54.
(5) Sethu AK, et al. Infect Control Hosp Epidemiol. 2010; 31(1): 21-27.
(6) Hota B. Clinical Infectious Diseases. 2004; 39: 1182-9.
(7) Boyce JM, Havill NL, Otter JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008; 29(8):723-729.
(8) Shapey S., Levi K., Machin K., Boswell T. C. difficile detection and control challenges: Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards, Journal of Hospital Infection. 2008, 70, 136-141. Available at: http://www.clinicalservicesjournal.com/Print.aspx?Story=7639.
(9) Johnson and Johnson Annual Report, 2010. Available at: http://www.investor.jnj.com/2010annualreport/pdf/2010-annual-report.pdf.
SOURCE Advanced Sterilization Products